MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 301 to 320 of 166,322 approvalsPage 16 of 8317

Norepinephrine Bitartrate Injection

Approval Number: 国药准字H20254320
Registration: May 27, 2025

Ambroxol Hydrochloride Oral Solution

Approval Number: 国药准字H20254360
Registration: May 27, 2025

Methocarbamol Injection

Approval Number: 国药准字H20254255
Registration: May 27, 2025

Fluorouracil Injection

Approval Number: 国药准字H20258091
Registration: May 26, 2025

Diprophylline Injection

Approval Number: 国药准字H20258092
Registration: May 26, 2025

Fluorouracil Injection

Approval Number: 国药准字H20258090
Registration: May 24, 2025

Sodium Hyaluronate Eye Drops

Approval Number: 国药准字H20258087
Registration: May 23, 2025

Famotidine Injection

Approval Number: 国药准字H20258089
Registration: May 23, 2025

Indobufen Tablets

Approval Number: 国药准字H20258088
Registration: May 23, 2025

Cefoperazone Sodium and Sulbactam Sodium for Injection

Approval Number: 国药准字H20258086
Registration: May 23, 2025

Cefoperazone Sodium and Sulbactam Sodium for Injection

Approval Number: 国药准字H20258085
Registration: May 23, 2025

Eldecalcitol Soft Capsules

Approval Number: 国药准字H20254209
Registration: May 20, 2025
广东江正药业有限公司

Choline Fenofibrate Sustained-release Capsules

Approval Number: 国药准字H20254220
Registration: May 20, 2025

Glecirasib Citrate Tablets

Approval Number: 国药准字H20250020
Registration: May 20, 2025

Lemborexant Tablets

Approval Number: 国药准字HJ20250057
Registration: May 20, 2025

Atosiban Acetate Injection

Approval Number: 国药准字H20254204
Registration: May 20, 2025

Epinephrine Hydrochloride Injection

Approval Number: 国药准字H20254200
Registration: May 20, 2025

Letermovir Tablets

Approval Number: 国药准字H20254189
Registration: May 20, 2025

Sodium Fluoride [18F] Injection

Approval Number: 国药准字H20254224
Registration: May 20, 2025

Glycerol Fructose and Sodium Chloride Injection

Approval Number: 国药准字H20254205
Registration: May 20, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.